Clinical trial
Evaluation of the Effects of Niacin Therapy on Lipoprotein Composition and Function
NCT02322203 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Effects of Niacin Therapy on Lipoprotein Composition and Function
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 25, 2015
- Completion date
- July 23, 2019
- Enrollment
- 22 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular disease